Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.6% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01247987Not ApplicableCompleted

Comparison of Transfers of Thawed Blastocysts Versus Blastocysts Derived From Thawed Bipronuclear Oocytes

Role: lead

NCT02031549Completed

Prospective Observational Correlation of Sperm Assay Results With Blastocyst Formation

Role: lead

NCT02028897Not ApplicableWithdrawn

Comparison of Alternative Embryo Culture Systems

Role: lead

NCT01184469Completed

Prospective Observational Study of Peri-implantation Serum hCG Levels

Role: lead

All 4 trials loaded